No Result

View All Result

No products in the cart.

2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑

Home StudyGraphics

#VisualAbstract: Apixaban does not significantly prevent recurrent stroke after cryptogenic stroke in patients with atrial cardiopathy

byMinjee Kim

February 27, 2024

in StudyGraphics

Reading Time: 1 min read

#VisualAbstract: Apixaban does not significantly prevent recurrent stroke after cryptogenic stroke in patients with atrial cardiopathy

Click here to read this study in JAMA.

©2024 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

RELATED REPORTS

Apixaban (Eliquis) is associated with reduced rates of ischemic stroke and bleeding in patients with atrial fibrillation and advanced chronic kidney disease compared with warfarin (Coumadin)

Antithrombotic agents may be effective in preventing migraine in patients with patent foramen ovale

Asundexian may reduce recurrent ischemic stroke without increased bleeding risk

Higher quantity of rib fractures may be a risk factor for venous thromboembolism

RelatedReports

Nephrology

Apixaban (Eliquis) is associated with reduced rates of ischemic stroke and bleeding in patients with atrial fibrillation and advanced chronic kidney disease compared with warfarin (Coumadin)

September 9, 2026

Prochlorperazine for migraine may lower likelihood of ED return

Chronic Disease

Antithrombotic agents may be effective in preventing migraine in patients with patent foramen ovale

August 7, 2026

Abusive head trauma results in fewer productive life-years

Cardiology

Asundexian may reduce recurrent ischemic stroke without increased bleeding risk

April 20, 2026

Differences in sudden unexpected infant death rates reported between states

Cardiology

Adjunctive prednisolone does not reduce coronary artery lesions in Kawasaki disease

April 15, 2026

$Bisphosphonate use and risk of atypical femur fractures$

Use of direct oral anticoagulants should not delay surgical intervention for patients with hip fractures

Implementation of pneumococcal vaccine programs linked to decreased antibiotic prescription

Early de-escalation from intravenous to oral antibiotics may be appropriate for uncomplicated gram-negative bacteremia

Dental procedures not associated with increased periprosthetic joint infections for knee arthroplasty

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

No Result

View All Result

#VisualAbstract: Apixaban does not significantly prevent recurrent stroke after cryptogenic stroke in patients with atrial cardiopathy

Apixaban (Eliquis) is associated with reduced rates of ischemic stroke and bleeding in patients with atrial fibrillation and advanced chronic kidney disease compared with warfarin (Coumadin)

Antithrombotic agents may be effective in preventing migraine in patients with patent foramen ovale

Asundexian may reduce recurrent ischemic stroke without increased bleeding risk

Higher quantity of rib fractures may be a risk factor for venous thromboembolism

Use of direct oral anticoagulants should not delay surgical intervention for patients with hip fractures

RelatedReports

Apixaban (Eliquis) is associated with reduced rates of ischemic stroke and bleeding in patients with atrial fibrillation and advanced chronic kidney disease compared with warfarin (Coumadin)

Antithrombotic agents may be effective in preventing migraine in patients with patent foramen ovale

Asundexian may reduce recurrent ischemic stroke without increased bleeding risk

Adjunctive prednisolone does not reduce coronary artery lesions in Kawasaki disease

Use of direct oral anticoagulants should not delay surgical intervention for patients with hip fractures

Early de-escalation from intravenous to oral antibiotics may be appropriate for uncomplicated gram-negative bacteremia

Dental procedures not associated with increased periprosthetic joint infections for knee arthroplasty

2MM+ All Access

Recent Reports

The medical literature, distilled daily.

Membership benefits